Font Size: a A A
Keyword [Small Cell Lung cancer]
Result: 161 - 180 | Page: 9 of 10
161. Study On The Effect Of HMGB1 Protein In Non-small Cell Lung Cancer
162. The Screening Of Different Proteins In NSCLC, The Expression Of XIAP And The Influence In The Chemotherapy
163. The Correlation Of VEGF Expression And Human Non-small-cell Lung Cancer
164. Clinical Study Of The Relationship Between Chemokine Receptor CCR7 And CXCR4 And Organ Metastases In Lung Cancer
165. Clinical Significance And Mechanism Of Up-Regulation Of CD4~+CD25~+FOXP3~+ Regulatory T Lymphocytes In Non-Small Cell Lung Cancer
166. δ-catenin Promotes Malignant Phenotype Of Non-small Cell Lung Cancer By Non-competitive Binding To E-cadherin With P120ctn In Cytoplasm
167. Involvement Of Hsa-miR-125a-3p And Hsa-miR-125a-5p In Non-small Cell Lung Cancer
168. The Relationship Between HDPR1 With Catenin Family Members Each Other In Non-Small Cell Lung Cancer
169. Initial Partial Response And Stable Disease Indicate Similar Progression-free Survival For Chemotherapeutical Patients With Advanced Non-small Cell Lung Cancer
170. Expression Of 14-3-3zeta And Its Influence On Tumor Development And Apoptosis In Stage T1 Non-small Cell Lung Cancer
171. Expression And Clinical Significance Of Survivin,P53 And Bcl-2 In ⅢA Non-small Cell Lung Cancer(NSCLC)before And After Neoadjuvant Chemotherapy
172. The Mechanism Of Gefitinib Resistance Induced By Hepatocyte Growth Factor In Sensitive Non-small Lung Cancer Cells
173. Hepatocellular Careinoma HepG2 Therapy Mediated By Tumor Suppressor Of Non-small Cell Lung Cancer 1
174. Effect Of NKTm Cells Plus Cisplatin/cetuximab Treatment On NSCLC Cells In Vitro
175. Concurrent Chemoradiotherapy For Locally Advanced Non-small Cell Lung Cancer Clinical Outcomes Of Patients With Malignant Lung Lesions Treated With Stereotactic Body Radiation Therapy
176. Expression Of Nm23 And E-cadherin In Stage Ⅰ Non-small Cell Lung Cancer, And Their Relationship With Lymph Node Micrometastasis And Prognosis
177. Anti-tumor Activity Of Fucoxanthin, An Active Ingredient Of Kelp Extract, Against Human NSCLC And Its Mechanism
178. Detection And Identification Of Serum Biomarkers Of Non-small Cell Lung Cancer
179. Research Of Health Technology Assessment For PET-CT In The Diagnosis Of Non-small Cell Lung Cancer
180. The Efficacy Prediction Of Tyrosine Kinase Inhibitor For Treatment Of Advanced Non-small Cell Lung Cancer And The Related Basic Research
  <<First  <Prev  Next>  Last>>  Jump to